Science and trust in animal health.

Yes. Medicavet was the first veterinary pharmaceutical company in Türkiye to earn GMP (Good Manufacturing Practice) certification from the Ministry of Agriculture. The facility and its processes are built to that standard, and every production batch passes 100% quality control before release. Medicavet also runs an ISO Integrated Quality Management System, so manufacturing, analysis and documentation follow the same auditable discipline that international registration dossiers require.

Medicavet was founded in 2003 with 100% domestic capital to manufacture animal-health products, and has stayed independent since. From that base it grew into a GMP-standard manufacturer exporting to more than 40 markets across the Middle East, the Balkans, the Turkic states, Asia and Africa. Research, production and quality control all run in house, staffed by a team of over 120 specialists that includes veterinarians, chemists, engineers and biologists.

Medicavet manufactures veterinary pharmaceuticals, disinfectants and feed additives to GMP standards. The portfolio spans oral powders, oral liquids, injectable solutions, vitamins and minerals, so distribution partners can source a full animal-health range from a single manufacturer. Production runs on two lines: liquid products for oral use, and oral powders. Neither line handles beta-lactam antibiotics. A batch is released only after Medicavet's own quality-control laboratory has tested it.

Medicavet develops products for poultry, cattle, sheep and goats, horses and aquaculture. Poultry and cattle account for the largest part of the catalogue, alongside a dedicated range for fish farming. Because species differ in how they absorb and eliminate a medicine, Medicavet formulates and documents each product for its target species rather than adapting one formulation across all of them. Which product suits a given case is a decision for the attending veterinarian.

Yes. Medicavet provides contract and private-label manufacturing for liquid and powder formulations at its cGMP-designed facility. The service runs end to end: analytical method development and validation, dissolution method work, long-term and accelerated stability studies, full quality-control testing, and GMP-compliant storage. Partners can bring Medicavet-made products to market under their own brand, with the documentation their national registration requires.

Medicavet exports to more than 40 markets across the Middle East, the Balkans, the Turkic states, Asia and Africa, and holds European registration for part of its range. The regulatory team prepares dossiers in CTD format, follows national or mutual-recognition procedures, and maintains pharmacovigilance reporting after approval. Registration status and available documentation differ by country, so Medicavet confirms product eligibility for each market before shipment.